KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Change in Intangibles (2020)

AbCellera Biologics (ABCL) has disclosed Change in Intangibles for 1 consecutive years, with $5.0 million as the latest value for Q1 2020.

  • For the quarter ending Q1 2020, Change in Intangibles changed N/A year-over-year to $5.0 million, compared with a TTM value of $5.0 million through Dec 2020, changed N/A, and an annual FY2023 reading of $560000.0, down 72.0% over the prior year.
  • Change in Intangibles was $5.0 million for Q1 2020 at AbCellera Biologics.
  • Across five years, Change in Intangibles topped out at $5.0 million in Q1 2020 and bottomed at $5.0 million in Q1 2020.